Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Ebola Drugs Shows Some Promise in First Test in West Africa

February 24, 2015 2:57 pm | by Marilynn Marchione, AP Medical Writer | News | Comments

An experimental antiviral drug shows some early, encouraging signs of effectiveness in its first human test against Ebola in West Africa. Read more...                  


Meet Sanofi's Newest CEO

February 24, 2015 11:13 am | by Ryan Bushey, Associate Editor | Articles | Comments

It took five months to find a new chief executive. Read more...                                 


NY Attorney General Expands Herbal Supplement Investigation

February 24, 2015 9:00 am | by Mary Esch, Associated Press | News | Comments

New York's attorney general is targeting manufacturers of the popular products. Read more...                            


Cryoport, Sanaria Expand Logistics Partnership Supporting Malaria Vaccines

February 24, 2015 8:55 am | News | Comments

This collaboration includes continued support of Sanaria’s production of malaria vaccine as well as its research and development efforts. Read more...                 


Shire Acquires Meritage Pharma

February 24, 2015 8:48 am | News | Comments

Shire paid an upfront fee of $70 million and additional contingent payments based on the achievement of development and regulatory milestones. Read more...                 


Researchers Discover Possible Drug Target to Combat Sleeping Sickness

February 24, 2015 8:42 am | by Virginia Tech | News | Comments

Biochemists are trying to deliver a stern wake-up call to the parasite that causes sleeping sickness. Read more...                        


Merck Grants Free License for Pediatric HIV Drug

February 24, 2015 8:33 am | by Linda A. Johnson, AP Business Writer | News | Comments

The deal lets any generic or brand name drug manufacturer make low-cost pediatric versions of Merck's raltegravir for sale in 92 low- and middle-income countries. Read more...              


Obesity-Type 2 Diabetes Molecular Link Reveals Potential Therapy

February 23, 2015 4:49 pm | News | Comments

Obesity causes inflammation, which can in turn lead to type 2 diabetes. What isn’t well established is how inflammation causes diabetes — or what we can do to stop it. Researchers at University of California, San Diego School of Medicine have discovered that the inflammatory molecule LTB4 promotes insulin resistance, a first step in developing type 2 diabetes. Read more..


Ancestry Helps Doctors Prescribe Hypertension Treatments

February 23, 2015 4:46 pm | News | Comments

Scientists are investigating whether treatment for high blood pressure can be improved by taking a person’s ethnic heritage into account. Read more...                                  


Customized DNA Rings Aid Early Cancer Detection in Mice

February 23, 2015 4:43 pm | by Bruce Goldman, Stanford | News | Comments

Imagine: You pop a pill into your mouth and swallow it. It dissolves, releasing tiny particles that are absorbed and cause only cancerous cells to secrete a specific protein into your bloodstream. Two days from now, a finger-prick blood sample will expose whether you’ve got cancer and even give a rough idea of its extent. Read more...


Worldwide Treatment of Hepatitis C: Within Sight At Right Cost?

February 23, 2015 4:37 pm | by University of Liverpool | News | Comments

Lowering the cost of hepatitis C drugs is possible and key to achieving global access to treatment, according to new research by the University of Liverpool and Imperial College London. Read more...


Liberia: 8 Hospital Staff Under Observation in Ebola Scare

February 23, 2015 4:25 pm | by Jonathan Paye-Layleh | News | Comments

Eight health workers at a hospital in Liberia's capital have been sent home for observation after coming into contact with a patient who later tested positive for Ebola, the country's assistant health minister said Saturday. Read more...


BioDelivery Sciences to Receive $10M from Endo Pharmaceuticals

February 23, 2015 10:56 am | News | Comments

BioDelivery Sciences International, Inc. and Endo Pharmaceuticals Inc., a subsidiary of Endo International plc announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for Belbuca. Read more..


Improving Patient Onboarding with Advancements in Medical Device Training

February 23, 2015 10:48 am | by Craig Baker, Executive Vice President, Noble | Articles | Comments

For some patients diagnosed with chronic medical conditions, weekly or biweekly self-administration using drug delivery devices is often a necessary component of a successful treatment program. Read more...


The Next Generation of Antibiotics Might Be Right Under Our Feet

February 23, 2015 10:21 am | News | Comments

The discovery of a new antibiotic called teixobactin was announced by international team of researchers, in January this year. It is the most significant new antibiotic to be discovered in more than 30 years, and it may help combat the growing number of drug-resistant bacteria. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.